I have us at T-49 today, just 7 full weeks to 150 days if the UK takes it to the end. I see all sorts of speculation on what NWBO will be paid for each patients vaccine post approval, and frankly, unless figures come from the company, and the regulators, it's meaningless speculation.
Until NWBO provides guidance on how it intends to take on worldwide commercial manufacturing, preservation, distribution and sales of the vaccine, nothing is really known.
I'm of the belief that the longer a patient to benefit from the vaccine, the more NWBO will be paid, but I could be completely wrong about that. NWBO's agreement with CDMO's could be to receive a fixed amount when the vaccine is initially made, and nothing th ereafter. My thinking is that more would be paid initially when the entire batch of vaccine is made, then a lesser amount for each dose, but again, it's just my thought on the matter. I would also speculate that if experience suggests that the more doses of the vaccine that's given the smaller the doses will get in order to stretch it out to many years. It's very possible that the benefits of the vaccine can be sustained with a dose that's a tiny fraction of the initial dose. This is purely speculation on my part, perhaps completely wrong, the point is, none of us really know.
What do we know? I believe that we know the vaccine is sustaining lives, but we can't yet say it's curative. We know that only so much vaccine can be made, and the volume made could vary with how much of the cancer you're working with in the beginning. If we have one dose remaining, can that dose be expanded on to make more? I know that some organic compounds can be duplicated, I don't know if this vaccine can be.
Give it time, we'll get answers, but only when we've received approvals and the company has determined how they intend to make the vaccine available eventually all over the world. Of course one possibility is for the company to be bought out, in that case they'd have no say on how things are to be done, and all of us should be far wealthier, but no longer speculating on what will happen.
Gary
